{"DataElement":{"publicId":"6681415","version":"1","preferredName":"Physician's Global Assessment  of Epidermal cGVHD Score 5 Point Scale","preferredDefinition":"A clinical outcome instrument to measure the severity of epidermal chronic graft versus host disease using a 5-point scale.","longName":"PGA_EPIDRM_CGVHD_SCL","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"6681236","version":"1","preferredName":"Physician's Global Assessment Scale of Epidermal Chronic Graft versus Host Disease Score","preferredDefinition":"A clinical outcome instrument to measure the severity of epidermal chronic graft versus host disease. Extent of cutaneous involvement is scored using a 5 point scale._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"6681234v1.0:2322175v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"6681234","version":"1","preferredName":"Physician's Global Assessment Scale of Epidermal Chronic Graft versus Host Disease","preferredDefinition":"A clinical outcome instrument to measure the severity of epidermal chronic graft versus host disease. Extent of cutaneous involvement is scored using a 5 point scale.","longName":"C158590","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physician's Global Assessment Scale of Epidermal Chronic Graft versus Host Disease","conceptCode":"C158590","definition":"A clinical outcome instrument to measure the severity of epidermal chronic graft versus host disease. Extent of cutaneous involvement is scored using a 5 point scale.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EDE89F-D03F-6A05-E053-F662850AC9B2","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2322175","version":"1","preferredName":"Score","preferredDefinition":"A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-04B2-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-02","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-08-02","modifiedBy":"ONEDATA","dateModified":"2005-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EDE89F-D04D-6A05-E053-F662850AC9B2","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-26","changeDescription":"Created for NCI-INC0362757 - 18AR0035 request 3/20/19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6681240","version":"1","preferredName":"PGA-cGVHD 5 Point Severity Scale","preferredDefinition":"An ordered reference standard used to measure incremental changes.","longName":"PGA_CGVHD_SCL","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"4","valueDescription":"Severe","ValueMeaning":{"publicId":"6681241","version":"1","preferredName":"Severe","longName":"6681241","preferredDefinition":"A score of 4 describing severe disease with confluent erythema and scale and/or papules covering >80% of target area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal cGVHD Score 4","conceptCode":"C158595","definition":"A score of 4 describing severe disease with confluent erythema and scale and/or papules covering >80% of target area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8E3E-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EB2FF4-8E57-63A4-E053-F662850A7A85","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"},{"value":"3","valueDescription":"Moderate","ValueMeaning":{"publicId":"6681242","version":"1","preferredName":"Moderate","longName":"6681242","preferredDefinition":"A score of 3 describing moderate disease with confluent erythema and scale and/or papules covering >50% of target area.\r\n \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal cGVHD Score 3","conceptCode":"C158594","definition":"A score of 3 describing moderate disease with confluent erythema and scale and/or papules covering >50% of target area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8E63-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EB2FF4-8E7C-63A4-E053-F662850A7A85","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"},{"value":"2","valueDescription":"Mild","ValueMeaning":{"publicId":"6681243","version":"1","preferredName":"Mild","longName":"6681243","preferredDefinition":"A score of 2 describing mild disease with erythema, fine scale and/or papules involving >20% of the target area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal cGVHD Score 2","conceptCode":"C158593","definition":"A score of 2 describing mild disease with erythema, fine scale and/or papules involving >20% of the target area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8E88-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EB2FF4-8EA1-63A4-E053-F662850A7A85","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"},{"value":"1","valueDescription":"Almost Clear","ValueMeaning":{"publicId":"6681244","version":"1","preferredName":"Almost Clear","longName":"6681244","preferredDefinition":"A score of 1 describing almost clear skin with light erythema, papules and/or scale involving 0-20% of the target area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal cGVHD Score 1","conceptCode":"C158592","definition":"A score of 1 describing almost clear skin with light erythema, papules and/or scale involving 0-20% of the target area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8EAD-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EB2FF4-8EC6-63A4-E053-F662850A7A85","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"},{"value":"0","valueDescription":"Clear","ValueMeaning":{"publicId":"6681245","version":"1","preferredName":"Clear","longName":"6681245","preferredDefinition":"A score of 0 describing clear skin where residual hyperpigmentation may be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidermal cGVHD Score 0","conceptCode":"C158591","definition":"A score of 0 describing clear skin where residual hyperpigmentation may be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8ED2-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"84EB2FF4-8EEB-63A4-E053-F662850A7A85","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"ONEDATA","dateModified":"2019-03-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2452834","version":"1","preferredName":"Scale","preferredDefinition":"an ordered reference standard.","longName":"C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0D51E8D8-69DD-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-02-24","modifiedBy":"ONEDATA","dateModified":"2006-02-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EB2FF4-8E24-63A4-E053-F662850A7A85","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-26","changeDescription":"Created for NCI-INC0362757 - 18AR0035 request. 3.20.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Physician's Global Assessment","type":"Preferred Question Text","description":"Physician's Global Assessment of epidermal cGVHD","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"84EE7E41-810B-4F53-E053-F662850A045F","latestVersionIndicator":"Yes","beginDate":"2019-03-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-03-25","modifiedBy":"COOPERM","dateModified":"2019-03-26","changeDescription":"Created for NCI-INC0362757 - 18AR0035 request 3.20.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}